因美纳推出TruPath Genome,树立基因组洞察新标准

美通社
Feb 25

TruPath™ Genome可提供更完整的基因组信息,并带来从样本到上机的极简工作流程 在AGBT发布的数据展示了TruPath Genome在罕见遗传病检测中的准确性 Broad Clinical Labs成为首批采用该产品的机构之一,该技术此前被称为"星座映射读取技术" 加利福尼亚州圣迭戈2026年2月25日 /美通社/ -- 2026年2月24日,因美纳(纳斯达克股票代码:ILMN)宣布...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10